Can omega-3 fatty acids reduce cardiovascular risk in children born with poor fetal growth: the Small baby Omega-3 (SO3) trial

Not Applicable

Recruiting

• Conditions: Cardiovascular - Hypertension; Cardiovascular - Other cardiovascular diseases; Small-for-gestational-age; Increased aortic intima-media thickness; Hypertension; Reproductive Health and Childbirth - Childbirth and postnatal care

• Registration Number: ACTRN12616000053426
• Lead Sponsor: The University of Sydney

Brief Summary

Results are not ready as the study is still active.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-01-20
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 576

Inclusion Criteria

Infants born at term (>37 weeks gestation) that are small-for-gestational-age (birth weight<10th percentile for sex and gestational age).

Exclusion Criteria

Multiple births, infants requiring surgery, illness in infant requiring hospitalization for more than 2 weeks, infants with significant neonatal disease, infants with chromosomal abnormalities or congenital malformations, fish oil contraindicated in mother.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Aortic intima-media thickness using an ultrasound machine[Aortic intima-media thickness will be measured at birth (enrolment), 6, 12, 18 months of age. The primary timepoint will be at 18 months of age.]